ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 180 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $159,853,000 | -9.1% | 12,850,000 | 0.0% | 44.03% | +8.7% |
| Q3 2016 | $175,916,000 | +85.3% | 12,850,000 | 0.0% | 40.51% | +50.3% |
| Q2 2016 | $94,961,000 | +15.6% | 12,850,000 | 0.0% | 26.95% | +49.0% |
| Q1 2016 | $82,111,000 | +2.2% | 12,850,000 | 0.0% | 18.09% | +15.9% |
| Q4 2015 | $80,313,000 | +7.0% | 12,850,000 | 0.0% | 15.61% | -15.8% |
| Q3 2015 | $75,044,000 | -29.4% | 12,850,000 | 0.0% | 18.53% | -24.2% |
| Q2 2015 | $106,270,000 | +0.4% | 12,850,000 | 0.0% | 24.46% | +9.5% |
| Q1 2015 | $105,884,000 | +19.9% | 12,850,000 | 0.0% | 22.34% | -28.5% |
| Q4 2014 | $88,280,000 | +27.2% | 12,850,000 | 0.0% | 31.25% | +16.6% |
| Q3 2014 | $69,390,000 | -9.2% | 12,850,000 | +7.1% | 26.80% | +3.1% |
| Q2 2014 | $76,440,000 | -21.0% | 12,000,000 | 0.0% | 25.99% | -21.9% |
| Q1 2014 | $96,720,000 | +18.2% | 12,000,000 | 0.0% | 33.30% | +8.7% |
| Q4 2013 | $81,840,000 | – | 12,000,000 | – | 30.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $82,111,000 | 18.09% |
| Consonance Capital Management LP | 5,575,742 | $35,629,000 | 5.39% |
| Opaleye Management Inc. | 1,250,000 | $7,988,000 | 4.98% |
| Tamarack Advisers, LP | 1,600,000 | $10,224,000 | 3.58% |
| Camber Capital Management LP | 5,405,235 | $34,539,000 | 2.02% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 324,636 | $2,074,000 | 1.36% |
| Palo Alto Investors LP | 2,248,317 | $14,367,000 | 1.12% |
| 1492 Capital Management LLC | 202,500 | $1,294,000 | 1.09% |
| Geduld E E | 120,100 | $767,000 | 1.05% |
| JS Capital Management LLC | 868,700 | $5,551,000 | 1.00% |